Marina Gartsbein

Title: Marina Gartsbein: Innovator in Inflammatory Disease Treatment

Introduction

Marina Gartsbein is a prominent inventor based in Tikva, Israel. She has made significant contributions to the field of medical treatment, particularly focusing on inflammatory diseases and disorders. Her innovative approach has led to the development of a unique method that utilizes specific modulators to address these health issues.

Latest Patents

Marina holds a patent for a method of treatment for inflammatory diseases and disorders. The patent, titled "Method for treatment of inflammatory disease and disorder," provides a comprehensive method, composition, and kit for treatment using PKC isoform modulators. Notably, the exemplary modulators include inhibitors of PKC-alpha, PKC-epsilon, and PKC-eta, as well as activators of PKC-delta. This patent highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Marina has demonstrated a strong dedication to research and innovation. She is currently associated with Healor Ltd., where she continues to develop and refine her methods for treating inflammatory conditions. Her work has garnered attention in the medical community, showcasing her expertise and innovative spirit.

Collaborations

Marina collaborates with esteemed colleagues, including Liora Braiman-Wiksman and Tamar Tennenbaum. These partnerships enhance her research efforts and contribute to the advancement of treatment methodologies in her field.

Conclusion

Marina Gartsbein is a trailblazer in the treatment of inflammatory diseases, with a patent that underscores her innovative contributions. Her work at Healor Ltd. and collaborations with fellow researchers position her as a key figure in medical innovation. Her dedication to improving health outcomes through scientific advancements is commendable.